15–19 years | 20–24 years | 25–29 years | 30–34 years | 35–39 years | 40–44 years | 45–49 years | 50–54 years | 55–59 years | 60+ years | |
Total number | 48 | 87 | 326 | 718 | 773 | 620 | 339 | 159 | 62 | 59 |
Total death | 2 | 12 | 37 | 69 | 81 | 72 | 38 | 20 | 5 | 8 |
Overall | 10.2 (7.6 to 14.1) | 7.1 (5.5 to 10.4) | 9.0 (7.6 to 10.4) | 8.7 (8.4 to 10.4) | 8.2 (7.8 to 9.8) | 7.5 (7.2 to 9.4) | 7.3 (6.7 to 9.5) | 7.0 (5.8 to 9.0) | 6.6 (5.3 to 8.3) | 3.8 (3.8 to 3.8) |
Gender | ||||||||||
Male | 8.0 (3.8 to 12.2) | 6.4 (3.3 to 9.5) | 6.7 (5.1 to 8.3) | 7.6 (6.5 to 8.7) | 6.9 (5.9 to 7.9) | 6.9 (5.8 to 8.1) | 7.0 (5.4 to 8.5) | 7.0 (5.0 to 8.9) | 6.5 (4.9 to 8.2) | 3.3 (3.3 to 3.3) |
Female | 12.7 (8.9 to 16.5) | 7.7 (3.9 to 11.5) | 10.5 (8.0 to 12.9) | 10.7 (8.8 to 12.7) | 10.7 (8.6 to 12.8) | 9.1 (6.8 to 11.3) | 8.6 (5.9 to 11.3) | 6.6 (3.7 to 9.6) | 6.7 (3.3 to 10.1) | 5.0 (5.0 to 5.0) |
Ethnicity | ||||||||||
Non-indigenous | 10.7 (5.6 to 15.8) | 7.9 (3.7 to 12.1) | 9.0 (6.8 to 11.1) | 8.9 (7.5 to 10.4) | 8.3 (6.8 to 9.7) | 7.4 (5.9 to 9.0) | 7.1 (5.2 to 9.1) | 7.3 (4.9 to 9.7) | 6.4 (4.3 to 8.6) | 3.8 (3.8 to 3.8) |
Indigenous | 9.4 (5.7 to 13.2) | 6.2 (3.5 to 8.9) | 7.4 (5.7 to 9.1) | 8.3 (7.1 to 9.5) | 7.7 (6.5 to 9.0) | 7.5 (6.1 to 9.0) | 7.6 (5.8 to 9.5) | 6.5 (4.4 to 8.7) | 6.8 (4.6 to 9.0) | 3.7 (3.7 to 3.7) |
CD4 cell count (cells/cm3) | ||||||||||
≤50 | 2.8 (0.8 to 4.8) | 1.3 (1.3 to 1.3) | 3.7 (2.3 to 5.1) | 4.9 (3.4 to 6.3) | 5.9 (4.3 to 7.5) | 6.0 (4.7 to 7.4) | 3.6 (2.6 to 4.6) | 2.4 (2.4 to 2.4) | 2.5 (2.4 to 8.4) | 2.4 (2.4 to 2.4) |
51–100 | 3.9 (−0.6 to 8.4) | 3.6 (0.8 to 6.4) | 5.2 (2.9 to 7.5) | 6.4 (4.9 to 7.8) | 4.8 (3.7 to 5.8) | 3.5 (2.5 to 4.5) | 6.4 (3.9 to 8.8) | 5.6 (2.6 to 8.5) | 4.7 (1.6 to 7.8) | 3.3 (3.3 to 3.3) |
101–200 | 9.4 (6.2 to 12.6) | 4.4 (1.3 to 7.6) | 9.1 (6.4 to 11.7) | 8.9 (6.9 to 10.8) | 9.2 (7.2 to 11.2) | 9.9 (7.5 to 12.3) | 9.2 (6.4 to 12.1) | 9.7 (6.5 to 12.9) | 8.7 (8.7 to 8.7) | 3.7 (3.7 to 3.7) |
>200 | 27.4 (22.3 to 32.6) | 22.4 (17.3 to 27.6) | 17.4 (12.3 to 22.6) | 18.1 (13.9 to 22.2) | 15.8 (11.6 to 20.1) | 15.8 (11.2 to 20.3) | 13.9 (9.1 to 18.7) | 13.1 (9.8 to 16.5) | 10.0 (10.0 to 10.0) | 5.0 (5.0 to 5.0) |
WHO clinical stage | ||||||||||
Stage I | 23.1 (16.6 to 29.7) | 18.1 (11.6 to 24.7) | 16.3 (12.5 to 20.1) | 13.9 (10.6 to 17.1) | 13.0 (9.6 to 16.4) | 11.5 (7.8 to 15.2) | 12.1 (7.8 to 16.3) | 12.0 (8.4 to 15.6) | 10.0 (10.0 to 10.0) | 5.0 (5.0 to 5.0) |
Stage II | 22.5 (14.6 to 30.4) | 17.5 (9.6 to 25.4) | 16.3 (11.1 to 21.5) | 18.5 (14.9 to 22.1) | 15.2 (11.7 to 18.8) | 14.0 (10.2 to 17.8) | 12.6 (8.5 to 16.7) | 12.1 (8.6 to 15.6) | 10.0 (10.0 to 10.0) | 5.0 (5.0 to 5.0) |
Stage III | 4.6 (1.5 to 7.6) | 3.1 (1.3 to 4.9) | 7.1 (4.8 to 9.3) | 8.4 (6.7 to 10.1) | 7.9 (6.3 to 9.6) | 7.7 (5.9 to 9.5) | 8.4 (5.9 to 10.8) | 7.2 (4.2 to 10.2) | 8.0 (5.8 to 10.1) | 4.2 (4.2 to 4.2) |
Stage IV | 6.2 (6.2 to 6.2) | 1.2 (1.2 to 1.2) | 2.6 (2.3 to 2.9) | 2.4 (2.4 to 2.4) | 2.9 (2.4 to 3.4) | 3.1 (2.4 to 3.7) | 2.7 (2.2 to 3.2) | 2.4 (2.4 to 2.4) | 1.7 (1.7 to 1.7) | 2.1 (2.1 to 2.1) |
Numbers inside parenthesis are 95% CI. Life expectancy was defined as the average number of additional years that will be lived by a person after that age.